Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 9, 2017
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $320 on, Nov 9th, 2017
Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Increased Target from $280 to $320 on, Nov 9th, 2017.
Ed has made no other calls on CDTX in the last 4 months.
There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, all agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Stephen Brozak of "WBB Securities" Upgraded from Strong Sell to Hold on, Friday, August 11th, 2017
